The full content of Annals is available to subscribers

Subscribe/Learn More  >
VI. Public Policy |

Clinical Investigators and the Pharmaceutical Industry

[+] Article, Author, and Disclosure Information

Grant support: by the Medical Research Service of the Veterans Administration.

▸Requests for reprints should be addressed to Calvin M. Kunin, M.D.; Medical Service, William S. Middleton Memorial Veterans Administration Hospital, 2500 Overlook Terrace; Madison, WI 53705.

Madison, Wisconsin

© 1978 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1978;89(5_Part_2):842-845. doi:10.7326/0003-4819-89-5-842
Text Size: A A A

Virtually all new drugs are introduced, evaluated, and marketed under the control of the pharmaceutical industry and general supervision of the Food and Drug Administration (FDA). The clinical investigator must look to the pharmaceutical industry for support of studies of drugs, and the industry, in turn, needs the investigator to evaluate agents before FDA approval and to present findings in the medical media. A survey of members of the Infectious Disease Society of America has shown heavy dependence on the pharmaceutical industry for support of applied studies of antibacterial and other chemotherapeutic agents. More than half the respondents believed that industry support was essential, about one third felt it was useful, and about one quarter would prefer other sources of support. Several proposals are presented to clarify the relations between investigators and the pharmaceutical industry and to provide for a broad-based clinical infectious disease consortium to provide research funds and plan educational programs in the field of infectious disease.


drug industry





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Integration of new technology into clinical practice after FDA approval. J Interv Card Electrophysiol Published online Aug 27, 2016;
Diterpenes from Grangea maderaspatana. Phytochemistry Published online Aug 23, 2016;
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.